Basal insulin levels in a Zulia state population in Venezuela;Niveles basales de insulina en una población del estado Zulia, Venezuela

Investigacion Clinica

Volumn 47, Issue 2, 2006, Pages

  Fernández, Virginia ^a   Clavell, Emilio ^a   Villasmil, José J ^a   Calmón, Gustavo ^a   Raleigh, Xiomara ^a   Morales, Luz Marina ^a   Campos, Gilberto ^a   Ryder, Elena ^a   Silva, Eglee ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Adult population; Basal insulin; References values

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; MALE; METABOLIC DISORDER; OBESITY; POPULATION RESEARCH; RADIOIMMUNOASSAY; REFERENCE VALUE; SAMPLE SIZE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; AGED; ANTHROPOMETRY; BLOOD; BLOOD PRESSURE; BODY MASS; DIET RESTRICTION; ETHNIC GROUP; MIDDLE AGED; VENEZUELA;

ADULT; AGED; ANTHROPOMETRY; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; ETHNIC GROUPS; FASTING; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; REFERENCE VALUES; THINNESS; TRIGLYCERIDES; VENEZUELA;

EID: 33745281236     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. White MF, Meyers MG Jr. The molecular basis of insulin action. En DeGroot LJ, Jameson JL (eds). Endocrinology. Fourth edition. WB Saunders Co. Philadelphia. 2001, p. 712-717.
2. Saltiel AR, Kahm CR. Insulin signalling and the regulation of glucosa and lipid metabolism. Nature 2001; 414:799-806.
3. Saltiel AR. Putting the brakes on insulin signaling. N Engl J Med 2003; 349:250-2562.
4. Lebovitz HE. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 2001; 109 (Suppl 2): S135-S148.
5. Kragelund C, Snorgaard O, Kobeer L, Bengtsson B, Ottesen M, Hojberg S, Olesen C, Kjaergaard JJ, Carlsen J, Torp-Petersen C, On Behalf Of The Trace Study Group. Hyperinsulinemia is associated with increased long-term mortality following acute myocardial infarction in non-diabetic patients. Eur Heart J 2004; 25: 1891-1897.
6. De Fronzo RA, Tobin JD, Andres R. Glucosa clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-E223.
7. Shen DC, Shieh SM, Fuh MMT, Wu DA, Chen YDI, Reaven GM. Resistance to insulin stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988; 66:580-583.
8. Hollenbeck CB, Chen N, Chen YDI, Reaven GM. Relationship between the plasma insulin response to oral glucose and insulin stimulated glucose utilization in normal subjects. Diabetes 1984; 33: 460-463.
9. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YDI, Sands RE, Pei D, Savage PJ, Bergman RN. The Insulin Resistance Atherosclerosis Study Group: A comparison between the minimal model and the glucose clamp in the assessment of insulin sensivity across the spectrum of glucose tolerance. Diabetes 1994; 43:1114-1121.
10. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993; 137:959-965.
11. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 1998; 68 (4): 899-917.
12. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002; 106:3743-3421.
13. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003; 26:3320-3325.
14. Kim SH, Abbasi F, Reaven GM. Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care 2004; 1998-2002.
15. Meigs JB, Wilson PWF, Nathan DM, D' Agostino RB, Williams K, Haffner SM. Prevalence and characteristics of metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes Care 2003; 52:2160-2167.
16. Carnevale GP, Rossi A, Sainaghi PP, Maduli E, Batoli E. The significance of impaired fasting glucose versus impaired glucose tolerance. Diabetes Care 2003; 26:1333-1337.
17. Ferrannini E, Nannipieri M, Willian K, Gonzales C, Haffner SM, Stern MP. Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes 2004; 53:160-165.
18. Pyöräla M, Miettinen H, Laakso M, Pyöräla K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policeman Study. Circulation 1998; 98:398-404.
19. Eschwege E, Ducimetiere P, Thibult N, Richard JL, Claude Jr, Rosselin GE. Coronary Heart disease mortality in relation with diabetes, blood glucose and plasma insulin level: the Paris prospective study 10 years later. Horm Metab Res 1985; 15 (suppl):41-45.
20. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996, 334:952-957.
21. Stout RW. Insulin and atheroma: 20-year perspective. Diabetes Care 1990; 13:631-655.
22. Kahn SE, Prigeon RL, Mcculloch DK, Boyko EJ, Bergman RN, Schawartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte D Jr. Quantification of the relationship between insulin sensivity and B-cell function in human subjects: evidence for hyperbolic function. Diabetes 1993; 42:1663-1672.
23. Ludvik B, Notan JJ, Baloga J, Sacks D, Plefsky J. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 1995; 44:1121-1125.
24. Howard G, O'leary DH, Zaccaro D, Haffner F, Rewers M, Hamman R, Selby JV, Saad MF, Savage PJ, Bergman R. The insulin resistance atherosclerosis study (IRAS). Insulin sensitive and atherosclerosis. Circulation 1996; 93:809-1817.
25. Watarai T, Yamasaki Y, Ikeda M, Kubota M, Kodama M, Tsujino T, Kishimoto M, Kawamori R, Hori M. Insulin resistance contributes to carotid arterial wall thickness in patients with non-insulin-dependent-diabetes mellitus. Endocr J 1999; 46:629-638.
26. Wohlin M, Sundsttom J, Arnlov J, Andren B, Zethelius B, Lind L. Impaired insulin sensivity is an independent predictor of common carotid intima-media thickness in a population sample of elderly men. Atherosclerosis 2003; 170:181-185.
27. Palaniappan LP, Carnethon MR, Fotmann SP Heterogeneity in the relationship between ethnicity, BMI, and fasting insulin. Diabetes Care 2002; 25:1351-1357.
28. Haffner SM, D'Agostino R Jr. Saad MF, Rewers M, Mykkänen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE, Bergman RN. Increased insulin resistance and insulin secretion in nondiabetic African-American and Hispanics compared with non-hispanic white. The insulin resistance atherosclerosis study. Diabetes 1996; 45:742-748.
29. Boyko EJ, Keane EM, Marshall JA, Hamman RF. Higher insulin and C-peptide concentration in hispanic populations at high risk for NIDDM. Diabetes 1991; 40:509-515.
30. Ryu S, Sung KC, Chang Y, Lee WY, Rhee EJ. Spectrum of insulin sensitivity in Korean population. Metabolism 2005; 12: 1644-1651.